| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,143 |
6,155 |
$450K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,927 |
2,697 |
$264K |
| 92587 |
|
1,084 |
1,066 |
$60K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
370 |
360 |
$45K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,906 |
2,763 |
$44K |
| 97802 |
|
1,835 |
1,754 |
$35K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,039 |
1,956 |
$27K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
235 |
229 |
$21K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
156 |
156 |
$15K |
| 90461 |
|
435 |
407 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
79 |
79 |
$8K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
515 |
479 |
$6K |
| 99215 |
Prolong outpt/office vis |
49 |
41 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
429 |
414 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
130 |
127 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
310 |
126 |
$3K |
| 99177 |
|
335 |
330 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
83 |
71 |
$1K |
| 81002 |
|
485 |
475 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
35 |
35 |
$861.45 |
| 99050 |
|
13 |
12 |
$536.52 |
| 92552 |
|
29 |
29 |
$484.93 |
| 96127 |
|
165 |
135 |
$469.33 |
| 0071A |
|
12 |
12 |
$389.90 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
82 |
71 |
$209.67 |
| 99188 |
|
13 |
13 |
$175.50 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
82 |
71 |
$3.08 |